Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.1 CAD
Market Closed
Updated:
May 18, 2024
Valeo Pharma Inc
EPS (Diluted)
|
Valeo Pharma Inc
EPS (Diluted) Peer Comparison
Comparables:
BHC
TH
K
GUD
EDT
CPH
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Valeo Pharma Inc
TSX:VPH
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
EPS (Diluted)
-$1
|
CAGR 3-Years
24%
|
CAGR 5-Years
23%
|
CAGR 10-Years
7%
|
|
|
Theratechnologies Inc
TSX:TH
|
EPS (Diluted)
$0
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-10%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
4%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
EPS (Diluted)
$0
|
CAGR 3-Years
71%
|
CAGR 5-Years
82%
|
CAGR 10-Years
0%
|
See Also
What is Valeo Pharma Inc's EPS (Diluted)?
EPS (Diluted)
-0.3
CAD
-0.3
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's EPS (Diluted) amounts to -0.3 CAD.
What is Valeo Pharma Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-36%
-36%
Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for Valeo Pharma Inc have been -59% over the past three years , -36% over the past five years .
You don't have any saved screeners yet
